Levien Meredith A. Kopit

Levien sold 9,750 NYT shares at $78.00 on 2026-05-12; stock down -13.3% from 52-week high, down -6.5% in 30 days.

Levien Meredith A. Kopit, President & CEO of The New York Times Co, sold 9,750 shares at $78.00 for $760,500.00, reducing holdings from 219.6K shares to maintain a significant ownership position. The sale occurred as NYT stock is -13.3% from its 52-week high and down -6.5% over the past 30 days, suggesting the insider chose to exit during a period of price weakness. His cross-ticker track record shows modest sell-timing accuracy (14.29% well-timed rate across 8 prior sells with +2.5% avg 30d return), while his prior trades at NYT have yielded mixed results—only 1 of 5 prior sells were well-timed at the 90-day mark. The timing of this sale amid recent downward momentum and well below the 52-week high warrants monitoring for whether it signals CEO concerns or reflects routine portfolio management against a backdrop of elevated valuation (P/E of 35.78).

CEO Meredith Kopit Levien sold 51,949 shares of NYT at $79.70; holds 229,362 shares post-sale. Stock now $81.95.

KOPIT LEVIEN MEREDITH A. (PRESIDENT & CEO) sold 51,949 shares at $79.70 on 2026-03-03, reducing her NYT holdings by 18.5% from 281,311 to 229,362 shares. The current price of $81.95 is +0.0% from the 52-week high, indicating the stock remains near its peak. Her prior trades at NYT show a pattern of poor timing: 0 of 5 prior sells were well-timed (stock rose in the subsequent 90 days following all five prior sales), averaging +8.0% returns after those sells. The sale occurred at $79.70, below today's price, but occurred when the stock was near its 52-week high and amid strong recent momentum (+13.5% over 30 days, +26.6% over 90 days). Fundamentally, the company shows solid metrics with $700.8M quarterly revenue, +9.2% annual growth, and $81.6M net income, though the P/E of 38.84 reflects a premium valuation.

NYT President & CEO Kopit Levien sells 16,972 shares at $59.68; stock now at $62.59 (52-week high).

Kopit Levien sold 16,972 shares on 2025-11-06 at $59.68, reducing her stake by 13.8%. The sale occurred while the stock was 0.0% from its 52-week high of $62.59, and has since appreciated to that peak price, meaning the sale occurred near the top of the recent range. Across her 5 prior trades at NYT, none of the 90-day post-sale returns were negative (all showed positive returns, from +4.4% to +12.5%), indicating a consistent pattern of poorly-timed sales at this ticker. Her cross-ticker track record shows an average 90d return of +7.1% following sells with a well-timed rate of 0.00%, reflecting similar timing challenges across her broader open-market activity. The P/E of 34.97 and revenue growth of +6.6% reflect a relatively expensive valuation, though this transaction alone does not clarify her view on fundamental value versus near-term momentum.

NYT CEO Meredith Kopit Levien sold 19,260 shares ($1.1M) on 2025-06-02, reducing holdings by 13.5% to 123,337 shares.

CEO Meredith Kopit Levien executed a $1.1M sale of 19,260 shares at $56.82, reducing her stake from 142.6K to 123.3K shares (a 13.5% reduction). The sale occurred near the 52-week high at -2.3% below peak, during a period of strong upward momentum: the stock advanced 6.8% over the prior 30 days and 17.9% over 90 days. Examining her NYT-specific selling history, all five prior sales at this ticker showed positive 90-day returns (ranging from +0.5% to +12.5%), indicating she has consistently sold before subsequent gains—a pattern of poorly-timed exits. Her cross-ticker track record similarly reflects muted timing discipline with a 0.00% well-timed rate across 5 prior sales. The company fundamentals remain solid with $635.9M in quarterly revenue, $49.6M net income, and 6.6% annual revenue growth, though a P/E of 31.19 reflects elevated valuation expectations.

NYT CEO Meredith A. Kopit Levien sold 19,869 shares at $50.53, reducing stake by 19.5% to 81,903 shares.

On 2025-02-13, Meredith A. Kopit Levien, President & CEO of New York Times Co., sold 19,869 shares at $50.53, reducing her holdings from 101,772 to 81,903 shares—a 19.5% reduction in her position. The stock now trades at $49.19, roughly -13.4% from its 52-week high of $56.83. Reviewing her same-ticker trade history at NYT, across four prior sells, zero were followed by declines within 90 days; instead, three of four generated positive 90-day returns (ranging from +0.5% to +12.5%), suggesting her prior sales have consistently missed subsequent rallies rather than avoiding downturns. Her cross-ticker track record shows an average 90-day return of +7.0% after prior sales with a well-timed rate of 0.00%, indicating a pattern of selling before appreciation rather than before declines. The current price decline of -5.2% over 30 days and -5.4% over 90 days represents a modest departure from her historical post-sale performance at this ticker, warranting observation to assess whether this sale marks a break in that pattern.

NYT CEO Meredith Kopit Levien sold 18,300 shares at $53.92; holds 101.8K shares post-sale.

KOPIT LEVIEN MEREDITH A., as President & CEO, sold 18,300 shares of NEW YORK TIMES CO for $986,772.60 on 2024-08-12, reducing her holdings from 120,072 to 101,772 shares (-15.2%). At current price of $54.56, the stock is -1.3% from its 52-week high of $55.29 and has climbed +13.8% over the past 90 days. Her same-ticker history shows 3 prior sales, none of which were well-timed at the 90-day mark; the most recent sale on 2024-05-10 saw the stock gain +12.5% in the subsequent 90 days, suggesting her prior sells did not precede material downturns. The company's fundamentals show Revenue of $625,097,000.00 and Net income of $65,540,000.00 in the latest quarter, with annual revenue growth of +5.1%, trading at a P/E of 38.70. The transaction occurs within a strong 90-day uptrend, and her cross-ticker selling track record shows a 0.00% well-timed rate, indicating her sales historically have not preceded declines.